Bio-Rad Laboratories EVP Sedat Evran Receives Annual RSU Award and Settles Vesting Shares
BIO-RAD LABORATORIES, INC.
Subscribe to track BIO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
BIO-RAD LABORATORIES, INC. (BIO) Form 4 Filing Summary
Insider: EVRAN SEDAT (EVP, Global Supply Chain)
Transaction Date: 2026-09-04 to 2026-09-06
- RSU Grant: 4,026 units (Code A)
- RSU Vesting: 1,891 Class A Common shares acquired at $0.00 (Code M)
- Tax Withholding: 606 Class A Common shares surrendered at $386.11 ($233,982.66 total value) (Code F)
Final Direct Common Stock Holdings: 3,603.12 shares
Trading Significance: Low (Routine Equity Award & Vesting)
Comprehensive Analysis
Executive Summary
On September 9, 2026, Bio-Rad Laboratories, Inc. ($BIO) filed a Form 4 on behalf of Sedat Evran, Executive Vice President of Global Supply Chain. The filing covers transactions taking place between September 4, 2026, and September 6, 2026, encompassing a new Restricted Stock Unit (RSU) award, the vesting of prior RSU tranches, and standard share withholdings to satisfy tax obligations.
Key Transaction Highlights
- RSU Award (2026-09-04): Granted 4,026 RSUs vesting over four years (25% on the first anniversary, followed by quarterly installments).
- RSU Vestings (2026-09-05 & 2026-09-06): Acquired an aggregate of 1,891 Class A Common shares upon the vesting of existing RSU grants at $0.00 per share.
- Tax Withholding (2026-09-05 & 2026-09-06): Surrendered 606 Class A Common shares (329 shares on Sept 5, 277 shares on Sept 6) at a market value of $386.11 per share (totaling ~$233,982.66) to cover statutory tax withholding requirements.
- Post-Transaction Holdings: Direct beneficial ownership of Bio-Rad Class A Common Stock stands at 3,603.12 shares following these transactions.
Market & Governance Impact
This filing reflects standard equity compensation activity and automated tax-withholding mechanisms rather than discretionary open-market buying or selling. Consequently, it carries Low trading significance for investors.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.